LCN2 and breast carcinoma: Vascular endothelial growth factor (VEGF), a key angiogenic activator, is significantly increased with higher Lcn2 expression in MCF-7 human breast cancer cells and TNBC cell line MDA-MB-436 and MDA-MB-231 cells [32].